03/10/2014 - 19:17
CHICAGO – A premenopausal breast cancer patient’s follicle-stimulating hormone level upon completion of chemotherapy predicts her risk of bone loss during the ensuing 12 months, Dr. Laila S....
Field of Interest: Oncology
Categories:
News Feed: Internal Medicine News - Oncology